Varian agrees to acquire Netherlands’ Claymount for €50m

29 July 2015 (Last Updated July 29th, 2015 18:30)

Varian Medical Systems has agreed to acquire Claymount, a Netherlands-based supplier of components and subsystems for x-ray imaging equipment manufacturers, for €50m.

Varian Medical Systems has agreed to acquire Claymount, a Netherlands-based supplier of components and subsystems for x-ray imaging equipment manufacturers, for €50m.

With manufacturing sites in the Netherlands, Philippines and the US, Claymount is one of the world's leading suppliers of high voltage connectors, ionisation chambers and solid state automatic exposure control systems for controlling doses during medical x-ray imaging.

The privately-held company also supplies buckies for digital radiography equipment, mammography paddles and x-ray collimators, as well as high-voltage generators for powering equipment.

"This acquisition will enhance our ability to support a continuing industry-wide transition from analogy to digital x-ray imaging."

Varian CEO Dow Wilson said: "Claymount's products complement our offerings and are a perfect fit for our Imaging Components business with great customer and channel synergies.

"This acquisition will enhance our ability to support a continuing industry-wide transition from analogy to digital x-ray imaging.

"This acquisition has the added benefit of being able to provide lower cost components for our Oncology Systems and Particle Therapy businesses."

With 250 employees, Claymount has annual revenues of nearly €30m. After the transaction, Claymount's team will operate under its managing director Joel Nijenhuis, who will report to Varian Imaging Components president, Sunny Sanyal.

Nijenhuis said: "There is a great strategic fit between both companies. We market a complementary product portfolio and can benefit from each other's knowledge and strengths.

"With a strong team on board and support from Varian, we can accelerate product development and expand our business. We look forward to this opportunity."

Executed through Variant's European subsidiary, the transaction is expected to be completed early next month.

Headquartered in Palo Alto, California, US, Varian produces medical devices and software to treat cancer and other medical conditions with radiation, and provides comprehensive solutions for radiotherapy, radiosurgery, proton therapy and brachytherapy.